Clinical Trial Update: A Randomized Phase II Study of Concurrent Chemoradiation With Every 3 Week of Cisplatin vs With Weekly Cisplatin in Locally Advanced Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase II randomized trial comparing concurrent chemoradiation with cisplatin given every 3 weeks versus weekly in locally advanced nasopharyngeal carcinoma; no …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: Samsung Medical Center | Conditions: Nasophayngeal Carcinoma Between Stage II and IVb | Phase 2 | Status: UNKNOWN